In this issue:
- Sexual health and QoL in early-stage cervical cancer
- Cervical cancer screening and treatment in Kenya
- Cost-effectiveness of pembrolizumab + chemoradiotherapy
- Pelvic exenteration for gynaecologic malignancies
- Universal screening for Lynch syndrome
- Chemoradiation vs chemotherapy for locally advanced endometrial cancer
- First-line lenvatinib + pembrolizumab for advanced endometrial cancer
- Mirvetuximab soravtansine for folate receptor α-positive ovarian cancer
- Low- versus high-dose bevacizumab in ovarian cancer
- Treatment of gestational trophoblastic disease
Please login below to download this issue (PDF)